Animal-Assisted Visitation Program Chlorhexidine Trial | MicrobiomeTrials← Back to trialsNCT04171817
Animal-Assisted Visitation Program Chlorhexidine Trial
CompletedPHASE4INTERVENTIONAL
Trial Details
Start: 2023-05-01Est. Completion: 2025-09-01
Enrollment target: 45 participants Locations- Johns Hopkins, Baltimore, Maryland, United States
- Washington University in St. Louis, St Louis, Missouri, United States
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Other microbiome trials you might be interested in
Cystic Fibrosis
This is an open-label, single center, prospective study of patients with a diagnosis of cystic fibrosis (CF) and a histo…
Cincinnati, United StatesCompleted Nov 30, 2024
Staphylococcus Aureus SepticemiaStaphylococcus Aureus BacteremiaS. Aureus BacteremiaS. Aureus Bloodstream InfectionStaphylococcus Aureus Endocarditis
This is an open label randomized controlled trial for patients with methicillin resistant S. aureus (MRSA) bloodstream i…
Concord, AustraliaEst. completion Jan 2027
Staphylococcus Aureus Bacteremia
The Staphylococcus aureus Network Adaptive Platform (SNAP) trial is an International Multi-Centered Randomised Adaptive …
Houston, United StatesEst. completion Dec 1, 2028